Skip to main content

Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | COVID-19 Testing | Vaccine InformationVaccine InformationVaccine Information

Explore URMC
menu

Clive S. Zent, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Research Labs

Visit Lab Website

Locations

Wilmot Cancer Institute Oncology
601 Elmwood Ave
Rochester, NY 14642-0001

Oncology: (585) 275-5823

Faculty Appointments

Patient Care Settings

Cancer, Hospital Medicine

Biography

I chose this specialty because I have always had an interest in diseases of the blood. My patients can be confident knowing I provide optimal individual patient care based on precision diagnosis and targeted therapy. Although I treat many types of blood diseases, my area of expertise is chronic lymphocytic leukemia.

Conditions I Treat:

- Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL)
- Hairy cell leukemia
- Prolymphocytic leukemia
- Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)
- Large granular lymphocytic leukemia

Professional Background

Dr. Clive Zent is a highly experienced hematologist and internationally recognized researcher and expert in the care of patients with chronic lymphocytic leukemia (CLL) and related lymphoid malignancies. While training in Hematology at the University of Chicago, Dr. Zent studied the molecular genetics of hematological malignancies in the laboratory of Dr. Janet Rowley. His clinical and research interest in CLL started as an attending physician at the Central Arkansas Veterans Healthcare System and continued when he joined the staff of the Mayo Clinic in Rochester MN in 2003. In 2013 he was appointed to the faculty of the Wilmot Cancer Center at the University of Rochester Medical Center as Professor of Medicine and director of the Chronic Lymphocytic Leukemia program.

Research

Dr. Zent's research has improved our understanding of the therapeutic monoclonal antibodies used to treat CLL, use of molecular prognostic markers in the management of CLL, diagnosis of CLL and related diseases, and evaluation and management of autoimmune cytopenias and second malignancies complicating CLL. His goal as a clinician, researcher and teacher is to continue to improve treatment and outcome for patients with CLL.

Credentials

Education

1983
MBBCH | University of Witwatersrand (South Africa)

Post-doctoral Training & Residency

07/01/1996 - 06/30/1997
Residency in Internal Medicine at University of Arkansas College of Medicine

07/01/1993 - 06/30/1996
Fellowship in Hematology at University of Chicago Medical Center

02/01/1987 - 01/31/1991
Residency in Internal Medicine at Groote Schuur Hospital (South Africa)

01/01/1984 - 12/31/1984
Internship in Internal Medicine at Coronation Hospital (South Africa)

VIEW ALL expand_more

Awards

2008
Teacher of the Year in Hematology
Sponsor: Mayo Fellows Association, College of Medicine
Location: Mayo Clinic

1995
Kaminer Fellowship (Travel Award)
Sponsor: University of Chicago
Location: Chicago, IL

1983
Degree with Distinction
Sponsor: University of the Witwatersrand
Location: South Africa

VIEW ALL expand_more

Publications

Journal Articles

7/18/2022
Anghelina M, Naughton MJ, Zhao Q, Ruppert AS, Neal J, Rogers KA, Blachly JS, Lozanski G, Bhat SA, Kraut E, Epperla N, Mathur P, Zent CS, Banerji V, Dearden C, Hutchinson T, Grever M, Andritsos LA. "Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia." Leukemia research.. 2022 Jul 18; 120:106919. Epub 2022 Jul 18.

5/2022
Nkosi D, Zent CS, El Hussein S. "Persistent polyclonal B-cell lymphocytosis: Illustration of the great mimicker of low-grade B-cell lymphoma." EJHaem.. 2022 May; 3(2):553-554. Epub 2022 Apr 19.

2/17/2022
Pinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, Van DerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC. "The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact." Haematologica.. 2022 Feb 17; Epub 2022 Feb 17.

Books & Chapters

2016
Chapter Title: Chronic lymphocytic leukemia/small lymphocytic lymphoma.
Book Title: ASH-SAP American Society of Hematology Self-Assessment Program
Author List: Zent CS, Call TG
Edited By: Steensma DP, Cuker A, Kempton CL
Published By: American Society of Hematology 2016

2010
Chapter Title: Chronic lymphocytic leukemia causing multiple mononeuropathies
Book Title: Companion to Peripheral Neuropathy: Illustrated Cases and New Developments
Author List: Mauermann ML, Zent CS, Low PA
Edited By: Dyck PJ, et.al.
Published By: Saunders/Elsevier 2010 in Philadelphia

2010
Chapter Title: Disorders of the Blood
Book Title: Textbook of Medicine
Author List: Zent C and Polliack A
Edited By: Warrel D, Cox T, Firth J
Published By: Oxford 2010

VIEW ALL PUBLICATIONS

Close Window

Schedule an appointment with Clive S. Zent, M.D.

Please answer the following questions to help us find the right appointment for you.

Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.

Have you seen this provider in the last 2 years?


Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.